Clinical Trial

Overdiagnosis and Breast Cancer Screening Decisions

Completed
View on ClinicalTrials.gov →
Summary
This is a survey-based study using an online panel. The goal of the study is to understand whether information about overdiagnosis influences breast cancer screening intention among older women. Participants are first asked a series of questions about breast cancer screening including their intention to continue screening, knowledge of screening, and beliefs about screening. They are then shown one of three videos about breast cancer screening that contain information about overdiagnosis or a fourth control video that is identical but contains no information about overdiagnosis. Participants are then again asked about screening intention, along with knowledge of screening, overdiagnosis, and questions around trust.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-07; most recent amendment 2026-07-15.
Status change: Recruiting → Completed 2025-10-27
Status change: Not Yet Recruiting → Recruiting 2025-07-23
Trial Details
NCT Number NCT07071415
Lead Sponsor Yale University
Collaborators: National Institutes of Health (NIH), National Cancer Institute (NCI)
Conditions Mammography Screening, Geriatrics, Decision Aid
Enrollment 308 participants
Start Date 2025-08-19
Primary Completion 2025-10-20 (estimated)
Study Completion 2025-10-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-17